The chemotherapeutic potential of Terminalia ferdinandiana: Phytochemistry and bioactivity

Pharmacognosy Reviews

Volumn 6, Issue 11, 2012, Pages 29-36

  Mohanty, S ^a   Cock, Ian E ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

antioxidants; Australian medicinal plants; gubinge; Kakadu plum; Terminalia ferdinandiana; vitamin C

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIN; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ARSENIC TRIOXIDE; ASCORBIC ACID; CHLOROPHYLL A; CHLOROPHYLL B; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; ELLAGIC ACID; ETOPOSIDE; GALLIC ACID; HESPERETIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; KAEMPFEROL; LUTEOLIN; MITOMYCIN C; PHENOL DERIVATIVE; PLANT MEDICINAL PRODUCT; QUERCETIN; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE; TERMINALIA FERDINANDIANA EXTRACT; UNCLASSIFIED DRUG; XANTHOPHYLL;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ATAXIA TELANGIECTASIA; BLADDER CANCER; BLOOM SYNDROME; BLUEBERRY; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CYSTITIS; DIABETES MELLITUS; DOWN SYNDROME; DRUG ACTIVITY; FANCONI ANEMIA; FRUIT; INFLAMMATION; LIVER CELL CARCINOMA; LYMPHOMA; MESOTHELIOMA; NEOPLASM; NERVE DEGENERATION; NONHUMAN; OBESITY; OVARY CANCER; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PHYTOCHEMISTRY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TERMINALIA; VITAMIN BLOOD LEVEL; XERODERMA PIGMENTOSUM;

PRUNUS DOMESTICA; TERMINALIA FERDINANDIANA; VACCINIUM;

EID: 84862059854     PISSN: 09737847     EISSN: 09762787     Source Type: Journal    
DOI: 10.4103/0973-7847.95855     Document Type: Review

References (91)

1. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 2003;66:1022-37.
2. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007;70:461-77.
3. Hegarty MP, Hegarty EE. Food safety of Australian Plant Bushfoods. Rural Ind Res Dev Corp 2001;1:34-5.
4. Pedley L. Combretaceae. Flora Aust 1995;18:255-93.
5. Brock J. Top End Native plants: A Comprehensive Guide to the Trees and Shrubs of the Top End of the Northern Territory. Sydney, Australia: Reed Books; 2001.
6. Cunningham AB, Garnett S, Gorman J, Courtenay K, Boehme D. Eco-Enterprises and Terminalia ferdinandiana: "Best Laid Plans" and Australian Policy Lessons. Econ Bot 2009;63:16-28.
7. Byrnes NB. A Revision of the Combretaceae in Australia. Queensland Herbarium, Brisbane, Australia; 1977.
8. Wheeler JR. Family 81 Combretaceae. In: Wheeler JR, editor. Flora of the Kimberley Region. Department of Conservation and Land Management, Como, Australia; 1992. p. 551-9.
9. Dunlop CR, Leach GJ, Cowie ID. Acacia. In Flora of the Darwin Region. Conservation Commission of the Northern Territory Botanical Bulletin 1995;20:1-21.
10. Gorman JT, Griffith AD, Whitehead PJ. An Analysis of the use of Plant Products for Commerce in Remote Aboriginal Communities of Northern Australia. Econ Bot 2006;60:362-73.
11. Konczak I, Zabaras D, Dunstan M, Aguas. Antioxidant capacity and hydrophilic phytochemicals in commercially grown Australian fruits. Food Chem 2010;123:1048-54.
12. Netzel M, Netzel G, Tian Q, Schwartz S, Konczak I. Native Australian fruits - a novel source of antioxidants for food. Innov Food Sci Emerg Technol 2007;8:339-46.
13. Potter JD. Cancer prevention: Epidemiology and experiment. Cancer Lett 1997;114:7-9.
14. Hertog MG, Bueno-de-Mesquita HB, Fehily AM, SweetnamPM, Elwood PC, Kromhout D. Fruit and vegetable consumption and cancer mortality in the caerphilly study. Cancer Epidemiol Biomarkers Prev 1996;5:673-7.
15. Vita JA. Polyphenols and cardiovascular disease: Effects on endothelial and platelet function. Am J Clin Nutr 2005;81:292S- 7S.
16. Youdim KA, Spencer JP, Schroeter H, Rice-Evans CA. Dietary flavonoids as potential neuroprotectans. Biol Chem 2002;383:503-19.
17. Tsuda T, Horio F, Uchida K, Aoki H, Osawa T. Dietary cyanidin 3-O-b- D-glucoside-rich purple corn colour prevents obesity and ameliorates hyperglycemia in mice. J. Nutr 2003;133:2125-30.
18. Rice-Evans C, Miller N, Paganga. Antioxidant properties of phenolic compound. Trends Plant Sci 1997;2:152-9.
19. Moskaug JO, Carlsen H, Myhrstad MC, Blomhoff R. Polyphenols and glutathione synthesis regulation. Am J Clin Nutr 2005;81:277-83S.
20. Moshi MJ, Mbwambo ZH. Some pharmacological properties of extracts f Terminalia sericea roots. J Ethnopharmacol 2005;97:43-7.
21. Fan YM, Xu LZ, Gao J, Wang Y, Tang XH, Zhao XN, et al. Phytochemical and anti-inflammatory studies on Terminalia catappa. Fitoterapia 2004;75:253-60.
22. Dwivedi S. Terminalia arjuna Wight & Arn - A useful drug for cardiovascular disorders. J Ethnopharmacol 2007;114:114-29.
23. Miller JB, James KW, Maggiore PM. Tables of composition of Australian Aboriginal foods. Aboriginal Studies Press, 1993; 256.
24. Woods B. A study of the intra-specific variations and commercial potenatial of Terminalia fredinandiana (the kakadu Plum). MSc thesis, Northern Territory University, Australia, 1995.
25. Johnson PD. Acerola (Malpighia glabra L., M. punicifolia L., M. emarginata D.C.): agriculture, production and nutrition. World Rev Nutr Diet 2003;91:67-75.
26. Cherikoff V, Kowalski G. Superfoods for Superhealth. Discover the Wonders of Australian Native Fruits. 2008 [Last cited on 2010 Oct 07]. Available from: http://www.kakadujuice.com/clientinc/ upload/Promotional.Tools/ SuperFoods%20Excerpt.pdf.
27. Losso JN, Bansode RR, Trappey A, Bawadi HA, Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 2004;15:672-78.
28. Ohno Y, Fukuda K, Takemura G, Toyota M, Watanabe M, Yasuda N, et al. Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999;10:845-51.
29. Motilva MJ. Chlorophylls - from functionality in food to health relevance. In: Heinonen M, editor. 5th Pigments in Food Congress - for quality & health, Proceedings of the 5th International Congress on Pigments in Food; Helsinki, Finland: 2008. p. 69-73.
30. Moser U, Bendich A. Vitamin C. In: Machlin LJ, editor. Handbook of vitamin C. 1st ed. Marcel Dekker: New York; 1991.
31. Barzilai A, Yamamoto KI. DNA damage responses to oxidative stress. DNA Repair 2004;3:1109-15.
32. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signaling. Curr Med Chem 2004;11:1163-82.
33. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004;266:37-56.
34. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of the aging. Nature 2000;408:239-47.
35. Halliwell B, Gutteridge MC. Free radicals in biology and medicine, 3rd ed. Oxford: Oxford University Press; 1999.
36. Saleh RA, Agarwal A. Oxidative Stress and Male Infertility: From Research Bench to Clinical Practice. J Androl 2002;23:737-52.
37. Kumagai S, Nobuhara Y, Saegusa J. Oxidative stress and autoimmune diseases. Nippon Naika Gakkai Zasshi 2003;92:1096-103.
38. Simic GM. Mechanisms of inhibition of free-radical processed in mutagenesis and carcinogenesis. Mutat Res 1988;202:377-86.
39. Gey KF. Cardiovascular disease and vitamins: Concurrent correction of 'suboptimal' plasma antioxidant levels may, as an important part of the 'optimal' nutrition, help to prevent early stages of cardiovascular disease and cancer, respectively. Bibl Nutr Dieta 1995;52:75-91.
40. Tafazoli S, Wright JS, O'Brien PJ. Proxidant and antioxidant activity of vitamin E analogues and troglitazone. Chem Res Toxicol 2005;18:1567-74.
41. Co̊kunŞ Gönül B, Güzel NA, Balabanli B. The effects of vitamin C supplementation on oxidative stress and antioxidant content in the brains of chronically exercised rats. Mol Cell Biochem 2005;280:135-8.
42. Sirdaarta J, Cock IE. Vitamin E and Trolox™ reduce toxicity of Aloe barbadensis Miller juice in Artemia franciscana nauplii but individually are toxic at high concentrations. Internet J Toxicol 2008;5(1) .
43. Driver C, Georgeou A. Variable effects of vitamin E on Drosophilia longevity. Biogerontol 2003;4:91-5.
44. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA. Metaanalysis: High dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37-46.
45. Pearson DA, Tan CH, German JB, Davis PA, Gershwin ME. Apple juice inhibits low density lipoprotein oxidation. Life Sci 1999;64:1913-20.
46. Farombi EO, Adepoju BF, Ola-Davies OE, Emerole GO. Chemoprotection of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by kolaviron, an natural biflavinoid of Garcinia kola seeds. Eur J Cancer Prev 2005;14:3,207-14.
47. Banerjee S, Panda CK, Das S. Clove (Syzgium aromaticum L.), a chemopreventitive agent for lung cancer. Carcinogenesis 2006;27:1645-54.
48. Cock IE, Mohanty S. Evaluation of the antibacterial activity and toxicity of Terminalia ferdinandia fruit extracts. Pharmacogn Mag Forthcoming 2011.
49. Klatt P, Lamas S. Regulation of protein function by Sglutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 2000;267:4928-44.
50. Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, et al. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J Biol Chem 1999;274:3182-8.
51. Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, Hayashi S, et al. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 1999;274:10363-71.
52. Hamilos DL, Zelarney P, Mascali JJ. Lymphocyte proliferation in glutathione-depleted lymphocytes: Direct relationship between glutathione availability and the proliferative response. Immunopharmacology 1989;18:223-35.
53. Kim HS, Lee JH, Kim IK. Intracellular glutathione level modulates the induction of apoptosis by delta 12-prostaglandin J2. Prostaglandins 1996;51:413-25.
54. Gabby M, Tauber M, Porat S, Simantov R. Selective role of glutathione in protecting human neuronal cells from dopamine induced apoptosis. Neuropharmacology 1996;35:571-8.
55. Iwata S, Hori T, Sato N, Hirota K, Sasada T, Mitsui A, et al. Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: Possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state. JImmunol 1997;158:3108-17.
56. Kim S, Gaber MW, Zawaski JA, Zhang F, Richardson M, Zhang XA, et al. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Biomaterials 2009;30:4743-51.
57. Cai J, Jones DP. Superoxide in apoptosis: Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 1998;273:11401-4.
58. Lodish H, Berk A, Matsudaira P, Kaiser CA, Kreiger M, Scott MP, et al. Molecular Cell Biology. 5th ed. New York: W.H. Freeman and Company; 2004.
59. Hanahan D,Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
60. Hancock V, Dahl M, Munk Vejborg R, Klemm P. Dietary plant components ellagic acid and tannic acid inhibit Escherichia coli biofilm formation. J Med Microbiol 2010;59:496-8.
61. Naz S, Siddiqi R, Ahmad S, Rasool SA, Sayeed SA. Antibacterial activity directed isolation of compounds from Punica granatum. J Food Sci 2007;72:341-5.
62. Fjaeraa C, Nanberg E. Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells. Biomed Pharmacother 2009;63:254-61.
63. Allen RG, Venkatraj VS. Oxidants and antioxidants in development and differentiation. J Nutr 1992;122:631-5.
64. Sohal RS, Allen RG. Oxidative stress as a causal factor in differentiation and aging: A unifying hypothesis. Exp Gerontol 1990;25:499-522.
65. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through redox state of the glutathione disulphide/ glutathione couple. Free Radic Biol Med 2001;30;1191-212.
66. Brown MR, Miller FJ, Li WG, Ellingson AN, Mozena JD, Chatterjee P, et al. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res 1999;85:524-33.
67. Yang M, Nazhat NB, Jiang X, Kelsey SM, Blake DR, Newland AC, et al. Adriamycin stimulates proliferation of human lymphoblastic leukaemic cells via a mechanism of hydrogen peroxide (H2O2) production. Br J Haematol 1996;95:339-44.
68. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995;18:775-94.
69. Alaluf S, Muir-Howie H, Hu HL, Evans A, Green MR. Atmospheric oxygen accelerates the induction of a post-mitotic phenotype in human dermal fibroblasts: The key protective role of glutathione. Differentiation 2000;66:147-55.
70. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric-oxide - a physiological messenger. Ann Intern Med 1994;120:227-37.
71. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000;29:323-33.
72. Haslett C. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 1992;83:639-48.
73. DeLong MJ. Apoptosis: A modulator of cellular homeostasis and disease states. Ann N Y Acad Sci 1998;842:82-90.
74. Wyllie AH, Kerr JF, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-306.
75. McConkey DJ, Hartzell P, Nicotera P, Wyllie AH, Orrenius S. Stimulation of endogenous endonuclease activity in hepatocytes exposed to oxidative stress. Toxicol Lett 1988;42:123-30.
76. Ashkenazi A, Dixit VM. Death receptors: Signalling and modulation. Science 1998;281:1305-8.
77. Pagano G, Korkina LG, Brunk UT, Chessa L, Degan P, del- Principe D, et al. Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: Prospects for joint research in pharmacology. Med Hypotheses 1998;51:253-66.
78. Tome ME, Baker AF, Powis G, Payne CM, Briehl MM. Catalaseoverexpressing thymocytes are resistant to glucocorticoidinduced apoptosis and exhibit increased net tumor growth. Cancer Res 2001;61:2766-73.
79. Michaud DS. Chronic inflammation and bladder cancer. Urol Oncol 2007;25:260-8.
80. Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC. An association of Cervical Inflammation with High -Grade Cervical Neoplasia in women infected with Oncogenic Human Papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001;10:1021-7.
81. Frenkel K, Wei L, Wei H. 7,12-Dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radic Biol Med 1995;19:373-80.
82. Boorstein RJ, Teebor GW. Mutagenicity of 5-hydroxymethyl- 2'-deoxyuridine to Chinese hamster cells. Cancer Res 1988;48:5466-70.
83. Frenkel K, Chrzan K. "Radiation-like modification of DNA and H2O2 formation by activated polymorphonuclear leukocytes (PMNs)", In: Cerutti P, Nygaard OF, Simic M, editors. Anticarcinogenesis and Radiation Protection. New York: Plenum Publishing Corp; 1987. p. 97-102.
84. Piipari R, Jaakkola JJ, Jaakkola N, Jaakkola MS. Smoking and asthma in adults. Eur Respir J 2004;24:734-9.
85. Nador GR, Cesarman E, Chadburn A, Dawson BD, Ansari QM, Said J, et al. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcomaassociated herpes virus. Blood 1996;88:645-56.
86. Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999;22:106-9.
87. Ness RB, Cottreau C. Possible role of Ovarian Epithelium Inflammation in Ovarian Cancer. J Natl Cancer Inst 1999;91:1459-67.
88. Karlson BM, Ekbom A, Josefsson S, McLaughlin JK, Fraumeni JF Jr, Nyrén O. The risk of Pancreatic Cancer following Pancreatitis: An association due to confounding? Gastroenterology 1997;113:587-92.
89. McEligot AJ, Yang S, Meyskens FL Jr. Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Annu Rev Nutr 2005;25:261-95.
90. Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW. p53/p21 (WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 1999;136:215-21.
91. Mohammad Shoeb. Anticancer agents from medicinal plants. Bangladesh J Pharmacol 2006;1:35-41.